16 research outputs found
Cigarette Smoke Decreases the Maturation of Lung Myeloid Dendritic Cells - Fig 1
<p><b>Gating strategy for each subtype of DCs</b>: (A) BDCA1-positive mDCs; (B) BDCA3-positive mDCs; (C) pDCs.</p
Subtypes and maturation markers (assessed by flow cytometry) of dendritic cells (expressed as percentages) in current and former smokers with COPD.
<p>Subtypes and maturation markers (assessed by flow cytometry) of dendritic cells (expressed as percentages) in current and former smokers with COPD.</p
Subtypes and maturation markers of dendritic cells (expressed as percentage) in different stages of COPD (stage 3 <i>versus</i> stages 1−2).
<p>Subtypes and maturation markers of dendritic cells (expressed as percentage) in different stages of COPD (stage 3 <i>versus</i> stages 1−2).</p
Distribution of dendritic cells and their subtypes in the study groups.
<p>No significant differences were identified.</p
General characteristics of the study groups.
<p>General characteristics of the study groups.</p
Subtypes and maturation markers of dendritic cells (expressed as percentages) in current smokers with COPD and control group.
<p>Subtypes and maturation markers of dendritic cells (expressed as percentages) in current smokers with COPD and control group.</p
Subtypes and maturation markers of dendritic cells (expressed as percentages) in current and former smokers non-COPD by flow cytometry.
<p>Subtypes and maturation markers of dendritic cells (expressed as percentages) in current and former smokers non-COPD by flow cytometry.</p
Associations between disease severity (expressed by spirometric impairment) and the percentage of dendritic cells measured by flow cytometry.
<p>Associations between disease severity (expressed by spirometric impairment) and the percentage of dendritic cells measured by flow cytometry.</p
Expression (assessed by flow cytometry) of the maturation markers CD40 and CD83 in different dendritic cell subtypes according to the smoking status.
<p>Expression (assessed by flow cytometry) of the maturation markers CD40 and CD83 in different dendritic cell subtypes according to the smoking status.</p
Recommendations regarding the clinical phenotypes and multidimensional evaluation.
<p>Recommendations regarding the clinical phenotypes and multidimensional evaluation.</p